BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9009241)

  • 1. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives.
    Selcer KW; Jagannathan S; Rhodes ME; Li PK
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):83-91. PubMed ID: 9009241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
    Selcer KW; Hegde PV; Li PK
    Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of potent non-estrogenic estrone sulfatase inhibitors.
    Li PK; Chu GH; Guo JP; Peters A; Selcer KW
    Steroids; 1998; 63(7-8):425-32. PubMed ID: 9654650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors.
    Kolli A; Chu GH; Rhodes ME; Inoue K; Selcer KW; Li PK
    J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):31-40. PubMed ID: 10215035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogenicity, antiestrogenicity and estrone sulfatase inhibition of estrone-3-amine and estrone-3-thiol.
    Selcer KW; Li PK
    J Steroid Biochem Mol Biol; 1995 Mar; 52(3):281-6. PubMed ID: 7696150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrone sulfate promotes human breast cancer cell replication and nuclear uptake of estradiol in MCF-7 cell cultures.
    Santner SJ; Ohlsson-Wilhelm B; Santen RJ
    Int J Cancer; 1993 Apr; 54(1):119-24. PubMed ID: 8478138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroidal oxathiazine inhibitors of estrone sulfatase.
    Peters RH; Chao WR; Sato B; Shigeno K; Zaveri NT; Tanabe M
    Steroids; 2003 Jan; 68(1):97-110. PubMed ID: 12475726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer.
    Duncan L; Purohit A; Howarth NM; Potter BV; Reed MJ
    Cancer Res; 1993 Jan; 53(2):298-303. PubMed ID: 8417823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of danazol on the conversion of estrone sulfate to estradiol and on the sulfatase activity in the MCF-7, T-47D and MDA-MB-231 human mammary cancer cells.
    Nguyen BL; Ferme I; Chetrite G; Pasqualini JR
    J Steroid Biochem Mol Biol; 1993 Jul; 46(1):17-23. PubMed ID: 8338787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of steryl sulfatase activity in LNCaP human prostate cancer cells.
    Selcer KW; Kabler H; Sarap J; Xiao Z; Li PK
    Steroids; 2002 Sep; 67(10):821-6. PubMed ID: 12231117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
    Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of estrone sulfatase enzyme in human placenta and human breast carcinoma.
    Evans TR; Rowlands MG; Jarman M; Coombes RC
    J Steroid Biochem Mol Biol; 1991 Oct; 39(4A):493-9. PubMed ID: 1911438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stilbene-based inhibitors of estrone sulfatase with a dual mode of action in human breast cancer cells.
    Walter G; Liebl R; von Angerer E
    Arch Pharm (Weinheim); 2004 Dec; 337(12):634-44. PubMed ID: 15597397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfamoyloxy-substituted 2-phenylindoles: antiestrogen-based inhibitors of the steroid sulfatase in human breast cancer cells.
    Golob T; Liebl R; von Angerer E
    Bioorg Med Chem; 2002 Dec; 10(12):3941-53. PubMed ID: 12413846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate.
    Purohit A; Williams GJ; Howarth NM; Potter BV; Reed MJ
    Biochemistry; 1995 Sep; 34(36):11508-14. PubMed ID: 7547880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors.
    Billich A; Nussbaumer P; Lehr P
    J Steroid Biochem Mol Biol; 2000; 73(5):225-35. PubMed ID: 11070351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
    Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV
    J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
    Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
    Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and sulfatase inhibitory activities of non-steroidal estrone sulfatase inhibitors.
    Li PK; Milano S; Kluth L; Rhodes ME
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):41-8. PubMed ID: 9009236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.